Stay updated on Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.

Latest updates to the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed. This update concerns internal versioning only and does not affect study details or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedA minor revision update was applied (from v3.4.0 to v3.4.1); no changes are observed in study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page adds a glossary display option and updates metadata text, replacing 'Last Update Submitted that met QC Criteria' with 'Last Update Submitted that Met QC Criteria', changing 'No FEAR Act data' to 'No FEAR Act Data', and adding the revision tag 'Revision: v3.4.0' in place of 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4, indicating a maintenance update with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a new Locations section listing the US states and Canadian provinces of the study sites and updated the page to revision v3.3.3.SummaryDifference2%

Stay in the know with updates to Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.